ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
Holding IPA?
Track your performance easily

ImmunoPrecise Antibodies (IPA) Cash flow

144 Followers

ImmunoPrecise Antibodies Cash Flow

IPA's free cash flow for Q1 2025 was C$-2.09M. For the 2025 fiscal year, IPA's free cash flow was decreased by C$-5.64M and operating cash flow was C$-1.82M. See a summary of the company’s cash flow.
Cash Flow
TTM
Apr 24Apr 23Apr 22Apr 21Apr 20
Operating Cash Flow
C$ -5.37MC$ -4.25MC$ -19.83MC$ -9.92MC$ -600.00KC$ -1.39M
Investing Cash Flow
C$ -1.63MC$ -1.56MC$ -1.97MC$ -5.21MC$ -2.46MC$ -1.58M
Financing Cash Flow
C$ 4.12MC$ 1.02MC$ -621.00KC$ 2.88MC$ 43.38MC$ 174.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 19.94MC$ 3.54MC$ 8.37MC$ 30.05MC$ 41.84MC$ 2.69M
Income Tax Paid Supplemental Data
--C$ 591.00K-C$ 1.10MC$ 238.00K
Interest Paid Supplemental Data
--C$ 263.00K-C$ 120.00KC$ 301.00K
Issuance Of Capital Stock
C$ 2.85MC$ 2.36MC$ 716.00KC$ 3.85MC$ 44.15MC$ 493.00K
Issuance Of Debt
C$ 1.27MC$ -1.34MC$ -1.34MC$ -962.00KC$ -772.00KC$ -319.00K
Repayment Of Debt
C$ -1.33MC$ -1.34M-C$ -962.00KC$ -2.97MC$ -915.00K
Free Cash Flow
C$ -6.89MC$ -5.64M-C$ -11.18MC$ -600.00KC$ -1.39M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

ImmunoPrecise Antibodies Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis